LONDON -- It was best that people interrupt their oral anticoagulation (OAC) therapy around the time they get transcatheter aortic valve replacement (TAVR, also TAVI), the POPular PAUSE TAVI trial ... With protamine routinely given at the end of transcatheter aortic valve replacement or implantation (TAVR or TAVI), patients achieved hemostasis quicker and with greater success, according to the ... Medscape: New TAVR Embolic Protection Device Holds Its Own in Head-to-Head Trial: PROTECT H2H A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the role of these devices remains unresolved.
New TAVR Embolic Protection Device Holds Its Own in Head-to-Head Trial: PROTECT H2H LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP) device with significant protection from stroke in patients undergoing ... Coronary artery disease frequently accompanies severe aortic stenosis and is identified in up to half of patients referred for transcatheter aortic valve implantation (TAVI).1 Yet the optimal ... EurekAlert!: Embolic protection device shows no effect on stroke risk with TAVR
